Prophecy, the AI data prep & analysis platform, today announced Prophecy v4, bringing AI agents based on Claude Code to business users for visual data preparation and analysis. Prophecy v4 generates ...

Entire raises $60M in seed funding at a $300M valuation, signaling strong investor confidence and rapid momentum in the fintech space.

Deal volumes are down, and the sector has slipped in funding rankings, even as the market heads towards $37 Bn+ by 2030 Marquee rounds like Innovaccer and PharmEasy have kept total funding steady, but ...

In early October, DualEntry, an AI enterprise resource planning (ERP) startup, announced a $90 million Series A round led by Lightspeed and Khosla Ventures, valuing the one-year-old business at $415 ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. Following a pilot, the Visa Commercial Solutions (VCS) Hub has ...

From right to left: Eileen Tanghal, MBA and Tara Bishop, MD, MPH, founders and managing directors at Black Opal Ventures. Venture capital is still a man’s game. Solely female-founded companies ...

As pitches from founders come flooding in, one investor has revealed how VCs use a historic "law" to identify the best investments. "The power law in venture capital basically means that a small ...

Venture capital-backed firms in Europe are on track for their worst year of fundraising since 2015, as investors avoid putting money in an industry that’s struggled with returns. Venture funds based ...

Have you ever felt the frustration of juggling multiple coding tasks, only to find your progress derailed by merge conflicts or overlapping changes? For developers working with Claude Code, an ...

VCs time exits around unlock schedules, use OTC deals, stagger sells and monitor market sentiment to maximize profits and minimize impact. Token unlocks release previously locked tokens into ...

U.S. venture capitalists are racing to tap in to China’s growing biotechnology prowess, a shift moving the industry into a more global market for the most promising new drug candidates. Several ...